Rankings
▼
Calendar
NMRA Q2 2021 Earnings — Neumora Therapeutics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
NMRA
Neumora Therapeutics, Inc. Common Stock
$559M
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$17M
Net Income
-$17M
EPS (Diluted)
$-0.11
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$14M
Stock-Based Comp.
$1M
← FY 2021
All Quarters
Q3 2021 →
